BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 2715168)

  • 21. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
    J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
    Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
    J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
    Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
    J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.
    Burger PC; Shibata T; Kleihues P
    Am J Surg Pathol; 1986 Sep; 10(9):611-7. PubMed ID: 2428262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vimentin and glial fibrillary acidic protein in human brain tumors.
    Yung WK; Luna M; Borit A
    J Neurooncol; 1985; 3(1):35-8. PubMed ID: 3889231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study.
    Klein R; Roggendorf W
    Acta Neuropathol; 2001 Mar; 101(3):245-8. PubMed ID: 11307624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cycling pool of cells within human brain tumors: in situ cytokinetics using the monoclonal antibody Ki-67.
    Tsanaclis AM; Robert F; Michaud J; Brem S
    Can J Neurol Sci; 1991 Feb; 18(1):12-7. PubMed ID: 1645210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
    Thotakura M; Tirumalasetti N; Krishna R
    J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
    Patt S; Giraldo M; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image analysis of proliferating cells in tumors of the human nervous system: an immunohistological study with the monoclonal antibody Ki-67.
    Hopf NJ; Bremm J; Bohl J; Perneczky A
    Neurosurgery; 1994 Nov; 35(5):917-23; discussion 923. PubMed ID: 7838342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
    Fazekas I; Kerekes E; Hegedús B; Nyáry I
    Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours.
    Ostertag CB; Volk B; Shibata T; Burger P; Kleihues P
    Acta Neurochir (Wien); 1987; 89(3-4):117-21. PubMed ID: 3324650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67.
    Giangaspero F; Doglioni C; Rivano MT; Pileri S; Gerdes J; Stein H
    Acta Neuropathol; 1987; 74(2):179-82. PubMed ID: 3673508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
    Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
    Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
    Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas.
    Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
    Surg Neurol; 1990 May; 33(5):320-4. PubMed ID: 1691866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
    Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
    Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis and cell proliferation in human neuroepithelial tumors.
    Schiffer D; Cavalla P; Migheli A; Chiò A; Giordana MT; Marino S; Attanasio A
    Neurosci Lett; 1995 Aug; 195(2):81-4. PubMed ID: 7478273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-time quantification of the proliferative state in astrocytomas.
    Ricco R; Cimmino A; Renzulli G; Serio G; Lozupone A; Lettini T; Pece A; Giardina C; Delfino VP
    Anal Quant Cytol Histol; 2000 Jun; 22(3):213-7. PubMed ID: 10872037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.